OKYO Pharma Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.0063 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
-7.19 | 4.82 | -249.08% |
|
|
| P/FCF |
|
-3.5 | 61 | -105.73% |
|
|
| Ev/Ebitda |
|
-2631.05 | -22.15 | 11777.72% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-4.37 | 68.78 | -106.35% |
|
|
| E/P |
|
-0.000507 | 0.0178 | -102.85% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
0.4 | 9.61 | -95.84% |
|
|
| ROA |
|
-0.4227 | 0.3443 | -222.78% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
0.3336 | 15.35 | -97.83% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-173.55 | -3.68 | 4621.47% | -43.44 | +299.5% |
| Nеt Debt/Ebitda |
|
52.51 | -3.44 | -1627.96% |
|
|
| Debt/Ratio |
|
1.77 | 0.1985 | 793.28% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-162.41 | 10.32 | -1673.22% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5468 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.2632 | -100% | ||
| DSI |
|
0 | 0.2193 | -100% |
|
|
| Average dividend growth |
|
0 | 0.4414 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4968 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5468 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-98.65 | -54.68 | 80.41% | ||
| Growth impulse Net Income in 5 years |
|
-98.61 | -58.33 | 69.06% | ||
| Growth impulse FCF in 5 years |
|
790.7 | -49.48 | -1698.02% | ||
| Growth impulse EPS in 5 years |
|
-99.57 | -32.41 | 207.22% |
IP Score
2.45/10
